DENND6B
gene geneOn this page
Also known as MGC33692AFI1B
Summary
DENND6B (DENN domain containing 6B, HGNC:32690) is a protein-coding gene on chromosome 22q13.33, encoding Protein DENND6B (Q8NEG7). Guanine nucleotide exchange factor (GEF) for RAB14.
Enables guanyl-nucleotide exchange factor activity. Predicted to be located in cytosol. Predicted to be active in recycling endosome.
Source: NCBI Gene 414918 — RefSeq curated summary.
At a glance
- GWAS associations: 2
- Clinical variants (ClinVar): 128 total
- MANE Select transcript:
NM_001001794
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:32690 |
| Approved symbol | DENND6B |
| Name | DENN domain containing 6B |
| Location | 22q13.33 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC33692, AFI1B |
| Ensembl gene | ENSG00000205593 |
| Ensembl biotype | protein_coding |
| OMIM | 620562 |
| Entrez | 414918 |
Gene structure
Transcript identifiers
Ensembl transcripts: 14 — 11 protein_coding, 3 retained_intron
ENST00000413817, ENST00000433760, ENST00000460087, ENST00000471942, ENST00000495607, ENST00000872969, ENST00000872970, ENST00000872971, ENST00000872972, ENST00000872973, ENST00000942388, ENST00000942389, ENST00000942390, ENST00000942391
RefSeq mRNA: 1 — MANE Select: NM_001001794
NM_001001794
CCDS: CCDS46732
Canonical transcript exons
ENST00000413817 — 20 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001629926 | 50314207 | 50314272 |
| ENSE00001707559 | 50326812 | 50327012 |
| ENSE00001773502 | 50313814 | 50313878 |
| ENSE00001812929 | 50309030 | 50312261 |
| ENSE00003490260 | 50312523 | 50312625 |
| ENSE00003507721 | 50314400 | 50314494 |
| ENSE00003516431 | 50314605 | 50314700 |
| ENSE00003523094 | 50318847 | 50318889 |
| ENSE00003588833 | 50315714 | 50315769 |
| ENSE00003591266 | 50316370 | 50316475 |
| ENSE00003601187 | 50312343 | 50312417 |
| ENSE00003619480 | 50316174 | 50316253 |
| ENSE00003638478 | 50316025 | 50316087 |
| ENSE00003644602 | 50317908 | 50318020 |
| ENSE00003653292 | 50314799 | 50314921 |
| ENSE00003676594 | 50317293 | 50317373 |
| ENSE00003681433 | 50318965 | 50319003 |
| ENSE00003682494 | 50312999 | 50313108 |
| ENSE00003683113 | 50313446 | 50313499 |
| ENSE00003693950 | 50313635 | 50313724 |
Expression profiles
Bgee: expression breadth ubiquitous, 179 present calls, max score 97.12.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 4.4664 / max 77.4706, expressed in 1258 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 194738 | 4.2707 | 1244 |
| 194737 | 0.1957 | 92 |
Top tissues by expression
242 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| right uterine tube | UBERON:0001302 | 97.12 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 91.40 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 90.46 | gold quality |
| cortical plate | UBERON:0005343 | 90.39 | gold quality |
| adenohypophysis | UBERON:0002196 | 90.38 | gold quality |
| cerebellar cortex | UBERON:0002129 | 90.29 | gold quality |
| right frontal lobe | UBERON:0002810 | 90.04 | gold quality |
| pituitary gland | UBERON:0000007 | 89.16 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.08 | gold quality |
| ventricular zone | UBERON:0003053 | 89.05 | gold quality |
| cerebellum | UBERON:0002037 | 88.50 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 88.22 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 87.70 | gold quality |
| prefrontal cortex | UBERON:0000451 | 86.52 | gold quality |
| nucleus accumbens | UBERON:0001882 | 85.87 | gold quality |
| hypothalamus | UBERON:0001898 | 85.38 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 85.18 | gold quality |
| bronchial epithelial cell | CL:0002328 | 85.09 | gold quality |
| neocortex | UBERON:0001950 | 85.04 | gold quality |
| caudate nucleus | UBERON:0001873 | 84.88 | gold quality |
| ganglionic eminence | UBERON:0004023 | 84.79 | gold quality |
| metanephros cortex | UBERON:0010533 | 84.65 | gold quality |
| frontal cortex | UBERON:0001870 | 84.61 | gold quality |
| amygdala | UBERON:0001876 | 84.31 | gold quality |
| bronchus | UBERON:0002185 | 84.07 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 83.79 | gold quality |
| left testis | UBERON:0004533 | 83.74 | gold quality |
| right testis | UBERON:0004534 | 83.67 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 83.17 | gold quality |
| putamen | UBERON:0001874 | 83.06 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 8.19 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
9 targeting DENND6B, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4692 | 100.00 | 67.32 | 2066 |
| HSA-MIR-4524A-3P | 99.72 | 66.85 | 2406 |
| HSA-MIR-3202 | 99.66 | 67.70 | 2737 |
| HSA-MIR-218-1-3P | 98.63 | 67.97 | 832 |
| HSA-MIR-3179 | 98.22 | 65.90 | 1445 |
| HSA-MIR-93-3P | 98.15 | 66.65 | 1309 |
| HSA-MIR-4329 | 97.68 | 66.26 | 1003 |
| HSA-MIR-939-5P | 97.10 | 65.80 | 1579 |
| HSA-MIR-1343-5P | 96.48 | 66.06 | 1506 |
Cross-species orthologs
5 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | dennd6b | ENSDARG00000011605 |
| mus_musculus | Dennd6b | ENSMUSG00000015377 |
| rattus_norvegicus | Dennd6b | ENSRNOG00000029866 |
| drosophila_melanogaster | CG3309 | FBGN0029756 |
| caenorhabditis_elegans | WBGENE00018777 |
Paralogs (1): DENND6A (ENSG00000174839)
Protein
Protein identifiers
Protein DENND6B — Q8NEG7 (reviewed: Q8NEG7)
Alternative names: DENN domain-containing protein 6B
All UniProt accessions (2): Q8NEG7, H0Y7N0
UniProt curated annotations — full annotation on UniProt →
Function. Guanine nucleotide exchange factor (GEF) for RAB14. Also has some, lesser GEF activity towards RAB35.
Subcellular location. Recycling endosome. Cytoplasm.
Similarity. Belongs to the DENND6 family.
RefSeq proteins (1): NP_001001794* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001194 | cDENN_dom | Domain |
| IPR024224 | DENND6 | Family |
| IPR037516 | Tripartite_DENN | Domain |
Pfam: PF02141
UniProt features (4 total): domain 3, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NEG7-F1 | 86.35 | 0.64 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-8876198 | RAB GEFs exchange GTP for GDP on RABs |
MSigDB gene sets: 79 (showing top):
REACTOME_MEMBRANE_TRAFFICKING, FOSTER_TOLERANT_MACROPHAGE_UP, TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_8D_UP, chr22q13, GOMF_GUANYL_NUCLEOTIDE_EXCHANGE_FACTOR_ACTIVITY, SANSOM_APC_MYC_TARGETS, SANSOM_APC_TARGETS_REQUIRE_MYC, GOCC_RECYCLING_ENDOSOME, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, DODD_NASOPHARYNGEAL_CARCINOMA_DN, MARTENS_TRETINOIN_RESPONSE_UP, GOBERT_OLIGODENDROCYTE_DIFFERENTIATION_DN, REACTOME_VESICLE_MEDIATED_TRANSPORT, REACTOME_RAB_GEFS_EXCHANGE_GTP_FOR_GDP_ON_RABS
GO Biological Process (0):
GO Molecular Function (1): guanyl-nucleotide exchange factor activity (GO:0005085)
GO Cellular Component (4): cytosol (GO:0005829), recycling endosome (GO:0055037), cytoplasm (GO:0005737), endosome (GO:0005768)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| Rab regulation of trafficking | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cellular anatomical structure | 2 |
| GTP binding | 1 |
| GDP binding | 1 |
| GTPase regulator activity | 1 |
| cytoplasm | 1 |
| endosome | 1 |
| intracellular anatomical structure | 1 |
| endomembrane system | 1 |
| cytoplasmic vesicle | 1 |
Protein interactions and networks
STRING
334 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DENND6B | RUSC2 | Q8N2Y8 | 497 |
| DENND6B | ACAP2 | Q15057 | 462 |
| DENND6B | PPP6R2 | O75170 | 462 |
| DENND6B | TMCO6 | Q96DC7 | 449 |
| DENND6B | OR9I1 | Q8NGQ6 | 448 |
| DENND6B | DENND10 | Q8TCE6 | 446 |
| DENND6B | GGNBP2 | Q9H3C7 | 438 |
| DENND6B | TBC1D22A | Q8WUA7 | 428 |
| DENND6B | DENND1A | Q8TEH3 | 411 |
| DENND6B | ATP6V1F | Q16864 | 408 |
| DENND6B | SYCE3 | A1L190 | 404 |
| DENND6B | DENND1B | Q6P3S1 | 401 |
| DENND6B | AVL9 | Q8NBF6 | 385 |
| DENND6B | TMEM116 | Q8NCL8 | 381 |
| DENND6B | SCFD1 | Q8WVM8 | 376 |
IntAct
7 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| DENND6B | MTA2 | psi-mi:“MI:0915”(physical association) | 0.400 |
| MYC | psi-mi:“MI:0914”(association) | 0.350 | |
| DENND6A | EML3 | psi-mi:“MI:0914”(association) | 0.350 |
| EBAG9 | psi-mi:“MI:0914”(association) | 0.350 | |
| LCOR | DENND6B | psi-mi:“MI:0915”(physical association) | 0.000 |
| DENND6B | UBA1 | psi-mi:“MI:0220”(ubiquitination reaction) | 0.000 |
BioGRID (13): DENND6B (Biochemical Activity), DENND6B (Proximity Label-MS), DENND6B (Affinity Capture-RNA), DENND6B (Affinity Capture-RNA), DENND6B (Affinity Capture-MS), DENND6B (Affinity Capture-MS), DENND6B (Proximity Label-MS), DENND6B (Proximity Label-MS), DENND6B (Two-hybrid), DENND6B (Affinity Capture-RNA), PTCD1 (Cross-Linking-MS (XL-MS)), MTA1 (Cross-Linking-MS (XL-MS)), APP (Reconstituted Complex)
ESM2 similar proteins: A4K436, A6NMX2, A6QLH6, A7Z026, B2RYF1, D4ABL6, E9PV86, F1QH17, O00459, O08908, O75864, O94759, O95260, P07903, P07992, P23726, P56223, P97679, Q0VGM9, Q1JQD7, Q1LZ75, Q29RM4, Q2PFX0, Q3KRC5, Q3U2P1, Q5R5M3, Q5RD33, Q5RE34, Q5RJZ1, Q5RKZ7, Q63788, Q6DC64, Q6H1L8, Q6ZN54, Q8BKR5, Q8CIW5, Q8NEG7, Q91XI1, Q96CN4, Q96FI4
Diamond homologs: Q54VA9, Q5F3L4, Q8BH65, Q8IWF6, Q8NEG7, Q9D9V7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
128 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 102 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2722 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 22:50312342:CCAG:C | donor_gain | 1.0000 |
| 22:50312413:ATGTT:A | acceptor_gain | 1.0000 |
| 22:50312414:TGTT:T | acceptor_gain | 1.0000 |
| 22:50312415:GTT:G | acceptor_gain | 1.0000 |
| 22:50312416:TT:T | acceptor_gain | 1.0000 |
| 22:50312416:TTCTG:T | acceptor_loss | 1.0000 |
| 22:50312417:TCT:T | acceptor_loss | 1.0000 |
| 22:50312418:C:CC | acceptor_gain | 1.0000 |
| 22:50312421:C:CT | acceptor_gain | 1.0000 |
| 22:50312426:C:CT | acceptor_gain | 1.0000 |
| 22:50312427:A:T | acceptor_gain | 1.0000 |
| 22:50312521:A:AC | donor_gain | 1.0000 |
| 22:50312522:C:CC | donor_gain | 1.0000 |
| 22:50312522:CCG:C | donor_gain | 1.0000 |
| 22:50312529:A:AC | donor_gain | 1.0000 |
| 22:50312530:C:CC | donor_gain | 1.0000 |
| 22:50312533:ATAG:A | donor_gain | 1.0000 |
| 22:50312535:AG:A | donor_gain | 1.0000 |
| 22:50312539:T:TA | donor_gain | 1.0000 |
| 22:50312594:A:T | acceptor_gain | 1.0000 |
| 22:50312622:CCGC:C | acceptor_gain | 1.0000 |
| 22:50312623:CGCC:C | acceptor_gain | 1.0000 |
| 22:50313104:GGAGT:G | acceptor_gain | 1.0000 |
| 22:50313107:GT:G | acceptor_gain | 1.0000 |
| 22:50313448:T:TA | donor_gain | 1.0000 |
| 22:50313630:CTCA:C | donor_loss | 1.0000 |
| 22:50313631:TCACC:T | donor_loss | 1.0000 |
| 22:50313632:CACC:C | donor_loss | 1.0000 |
| 22:50313633:A:AC | donor_gain | 1.0000 |
| 22:50313633:AC:A | donor_gain | 1.0000 |
AlphaMissense
3793 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 22:50326839:G:C | F50L | 1.000 |
| 22:50326839:G:T | F50L | 1.000 |
| 22:50326841:A:G | F50L | 1.000 |
| 22:50314467:G:C | N335K | 0.999 |
| 22:50314467:G:T | N335K | 0.999 |
| 22:50316233:A:G | W194R | 0.999 |
| 22:50316233:A:T | W194R | 0.999 |
| 22:50316475:A:G | S152P | 0.999 |
| 22:50317998:G:C | F94L | 0.999 |
| 22:50317998:G:T | F94L | 0.999 |
| 22:50318000:A:G | F94L | 0.999 |
| 22:50326840:A:C | F50C | 0.999 |
| 22:50314477:C:T | G332E | 0.998 |
| 22:50314478:C:G | G332R | 0.998 |
| 22:50314478:C:T | G332R | 0.998 |
| 22:50316474:G:A | S152F | 0.998 |
| 22:50317296:C:A | Q150H | 0.998 |
| 22:50317296:C:G | Q150H | 0.998 |
| 22:50317338:G:C | F136L | 0.998 |
| 22:50317338:G:T | F136L | 0.998 |
| 22:50317340:A:G | F136L | 0.998 |
| 22:50317351:C:T | G132D | 0.998 |
| 22:50326825:C:T | G55D | 0.998 |
| 22:50326840:A:G | F50S | 0.998 |
| 22:50326841:A:C | F50V | 0.998 |
| 22:50326841:A:T | F50I | 0.998 |
| 22:50326868:A:G | W41R | 0.998 |
| 22:50326868:A:T | W41R | 0.998 |
| 22:50314471:G:A | T334I | 0.997 |
| 22:50314660:A:C | Y308D | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000154582 (22:50311810 C>T), RS1000228583 (22:50310782 C>A), RS1000255006 (22:50311668 T>C), RS1000666891 (22:50311125 C>T), RS1000839053 (22:50320739 A>C), RS1000885248 (22:50316648 T>C), RS1000889111 (22:50309675 T>C), RS1000923418 (22:50326579 G>A), RS1000935765 (22:50320730 T>C), RS1000983662 (22:50315724 C>A,G,T), RS1001070773 (22:50321220 C>T), RS1001124369 (22:50321756 T>C), RS1001136519 (22:50326667 G>C), RS1001211399 (22:50328745 C>T), RS1001404042 (22:50326798 TCGCGCC>T,TCGCGCCCGCGCC)
Disease associations
OMIM: gene MIM:620562 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
2 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST002481_12 | Acne (severe) | 4.000000e-06 |
| GCST008595_234 | Cognitive ability, years of educational attainment or schizophrenia (pleiotropy) | 4.000000e-08 |
EFO canonical traits (2, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004337 | intelligence |
| EFO:0004784 | self reported educational attainment |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
20 total (human), top 20 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Smoke | decreases expression, increases abundance, increases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| aflatoxin B2 | increases methylation | 1 |
| beta-methylcholine | affects expression | 1 |
| ICG 001 | increases expression | 1 |
| palbociclib | increases expression | 1 |
| jinfukang | increases expression, affects cotreatment | 1 |
| 4-(4-((5-(4,5-dimethyl-2-nitrophenyl)-2-furanyl)methylene)-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl)benzoic acid | increases expression | 1 |
| Erlotinib Hydrochloride | decreases expression | 1 |
| Temozolomide | decreases expression | 1 |
| Sunitinib | decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Calcitriol | increases expression | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Valproic Acid | increases methylation | 1 |
| Okadaic Acid | decreases expression | 1 |
| Acrylamide | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.